Weill-Marchesani Syndrome is a rare genetic disorder that causes abnormal features at birth. Weill-Marchesani Syndrome is characterized by a broad head, short stature, hand abnormalities, and eye defects. The defects of the eye vary dramatically from minimal problems to blindness. There is no cure for Weill-Marchesani Syndrome, but eye surgery can be performed to help vision irregularities.
Weill-marchesani Syndrome Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Weill-marchesani Syndrome below!
For more information on how to use Laverne, please read the How to Guide.
We have 1253 products for the study of Weill-marchesani Syndrome that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Weill-marchesani Syndrome is also known as weill-marchesani syndrome, spherophakia-brachymorphia syndrome, weill-marchesani syndrome, autosomal recessive, mesodermal dysmorphodystrophy, congenital, congenital mesodermal dysmorphodystrophy, mesodermal dysmorphodystrophy congenital, spherophakia brachymorphia syndrome, congenital mesodermal dystrophy, neonatal hemochromatosis, marchesani syndrome, wm syndrome.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.